Prostate cancer is the second most commonly diagnosed cancer in men globally, according to the World Health Organisation (WHO ...

Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.

New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate-specific antigen relapse.

Breakthrough for prostate cancer patients as NHS now offers life-extending drug - The new medication is suitable for patients ...

An individual-patient meta-analysis sheds light on the optimal duration of androgen deprivation therapy in men with prostate cancer on definitive radiotherapy.

Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

A groundbreaking study at Rabin Medical Center suggests prostate cancer patients may need only two radiation doses, ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have launched a clinical trial, called ANDROMEDA, to ...

University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...